AU660420B2 - Method for treating immune system dysfunctions - Google Patents
Method for treating immune system dysfunctions Download PDFInfo
- Publication number
- AU660420B2 AU660420B2 AU84333/91A AU8433391A AU660420B2 AU 660420 B2 AU660420 B2 AU 660420B2 AU 84333/91 A AU84333/91 A AU 84333/91A AU 8433391 A AU8433391 A AU 8433391A AU 660420 B2 AU660420 B2 AU 660420B2
- Authority
- AU
- Australia
- Prior art keywords
- immune system
- lys
- dynorphin
- patient
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56239390A | 1990-08-03 | 1990-08-03 | |
US562393 | 1990-08-03 | ||
PCT/US1991/005518 WO1992002547A1 (en) | 1990-08-03 | 1991-08-02 | Method for treating immune system dysfunctions |
Publications (2)
Publication Number | Publication Date |
---|---|
AU8433391A AU8433391A (en) | 1992-03-02 |
AU660420B2 true AU660420B2 (en) | 1995-06-29 |
Family
ID=24246112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU84333/91A Ceased AU660420B2 (en) | 1990-08-03 | 1991-08-02 | Method for treating immune system dysfunctions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0541694A1 (ja) |
JP (1) | JPH06501930A (ja) |
AU (1) | AU660420B2 (ja) |
CA (1) | CA2088679A1 (ja) |
WO (1) | WO1992002547A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817628A (en) * | 1992-12-02 | 1998-10-06 | The Rockefeller University | Dynorphin a suppression of natural killer cell activity |
US20190241660A1 (en) * | 2017-12-05 | 2019-08-08 | Intendet Services, Llc | Immune-stimulating peptides and checkpoint inhibitors, and uses thereof for treating cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4537878A (en) * | 1981-10-05 | 1985-08-27 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to stimulate the immune system |
US4757049A (en) * | 1981-10-05 | 1988-07-12 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to stimulate the immune system of patients with aids |
US4801614A (en) * | 1981-10-05 | 1989-01-31 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells |
-
1991
- 1991-08-02 JP JP3514500A patent/JPH06501930A/ja active Pending
- 1991-08-02 EP EP91915040A patent/EP0541694A1/en not_active Withdrawn
- 1991-08-02 WO PCT/US1991/005518 patent/WO1992002547A1/en not_active Application Discontinuation
- 1991-08-02 AU AU84333/91A patent/AU660420B2/en not_active Ceased
- 1991-08-02 CA CA002088679A patent/CA2088679A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4537878A (en) * | 1981-10-05 | 1985-08-27 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to stimulate the immune system |
US4757049A (en) * | 1981-10-05 | 1988-07-12 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to stimulate the immune system of patients with aids |
US4801614A (en) * | 1981-10-05 | 1989-01-31 | Tni Pharmaceuticals, Inc. | Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells |
Also Published As
Publication number | Publication date |
---|---|
EP0541694A4 (ja) | 1994-03-09 |
CA2088679A1 (en) | 1992-02-04 |
JPH06501930A (ja) | 1994-03-03 |
WO1992002547A1 (en) | 1992-02-20 |
EP0541694A1 (en) | 1993-05-19 |
AU8433391A (en) | 1992-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shavit et al. | Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity | |
Ben-Eliyahu et al. | Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and β-adrenoceptors | |
Old | Tumor necrosis factor | |
CA2137916A1 (en) | Des-tyr dynorphin analogues | |
Dafny et al. | Immune response products alter CNS acitivity: Interferon modulates central opioid function | |
AU2005307814A1 (en) | Histone deacetylase inhibitors and methods of use | |
JPH08502024A (ja) | インターフェロン−αとヒスタミン、セロトニン、アミン類または相当するレセプター活性を有する物質とを含有するナチュラルキラー細胞(NK細胞)活性化用製剤 | |
CA2199730A1 (en) | Protection of hemopoietic cells during chemotherapy or radiotherapy | |
Takahashi et al. | A tumor necrosis factor (TNF) receptor fragment attenuates TNF‐α‐and muramyl dipeptide‐induced sleep and fever in rabbits | |
Saphier et al. | α-Interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat | |
AU660420B2 (en) | Method for treating immune system dysfunctions | |
WO1997015595A1 (en) | Method of mobilizing hematopoietic stem cells | |
US5534495A (en) | Treatment of non-HIV neuropathic pain syndromes | |
Bayer et al. | Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation | |
US5807827A (en) | Des-Tyr dynorphin analogues | |
Kreek | Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms | |
JPH11510806A (ja) | 免疫抑制治療のためのインターロイキン10およびシクロスポリンの併用 | |
WO1993002692A1 (en) | Method of combatting hiv infections | |
Roy et al. | Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells | |
Nicoletti et al. | Prevention of cyclophosphamide‐induced diabetes in the NOD/WEHI mouse with deoxyspergualin | |
Nakano et al. | Accelerated recovery of antigen-presenting cell activity by the administration of interleukin 1α in 5-fluorouracil-treated mice | |
KR102398968B1 (ko) | 조혈 줄기세포의 가동을 위한 물질-p의 배합 요법 | |
EP1641431A2 (en) | Uses of il-12 in hematopoiesis | |
US4929640A (en) | Medicaments intended for combined use in the improvement of lymphocyte function | |
Bodner et al. | The Effects of Dynorphin Peptides on Human Natural Killer Cell Activity In Vitro |